Skip to content

Treatment of bronchiolitis

Evaluation of response to treatment and comparison of normal saline and hypertonic saline nebulizer in the bronchiolitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151003024317N6
Enrollment
60
Registered
2019-08-19
Start date
2019-09-16
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis. Acute bronchiolitis

Interventions

Intervention 1: Control group: Patients will receive 3 ml normal saline 0.9% each 20 minutes for 3 times and 8 liters of oxygen per minute via nebulizer. Intervention 2: Intervention group: Patients w

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 10 Years

Inclusion criteria

Inclusion criteria: Clinical evidence of respiratory viral infection Body temperature 38 degrees Celsius and above Abnormal breathing rate based on age range High heart rate due to age range coryza Age over 1 year

Exclusion criteria

Exclusion criteria: History of more than two episodes of respiratory distress in the past, Chronic heart and pulmonary disease Safety defect Down syndrome Metabolic or neurological disease Use of mechanical ventilation in neonatal period Positive family history of asthma Sick patient requiring immediate hospitalization due to dehydration, decreased consciousness, lethargy, or respiratory failure symptoms Age over 10 years

Design outcomes

Primary

MeasureTime frame
Saturation of oxygen. Timepoint: On arrival, 10 minutes after the first nebulizer, 10 minutes after the second nebulizer; 10 minutes after the third nebulizer. Method of measurement: Pulse Oximetry.;The number of pulses. Timepoint: On arrival, 10 minutes after the first nebulizer, 10 minutes after the second nebulizer; 10 minutes after the third nebulizer. Method of measurement: Based on patient records.;Breath rate. Timepoint: On arrival, 10 minutes after the first nebulizer, 10 minutes after the second nebulizer; 10 minutes after the third nebulizer. Method of measurement: Based on patient records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamane Sadat Khoobbin Khoshnazar

Iran University of Medical Sciences

Samanekhoshnazar@gmail.com+98 21 86701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026